PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA3HW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $13,817
Award facts
- Contract value 100% obligated
- $13,817.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a $13,817.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 5, 2026, with an ultimate completion date of January 6, 2026. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order exemplifies AmerisourceBergen's role as a primary vendor within the DLA's pharmaceutical supply chain infrastructure. The company's IDC serves as a global pharmaceutical support vehicle enabling supply of critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. AmerisourceBergen's consistent competitively awarded contracts with the DLA demonstrate its capability to meet federal procurement requirements through open competition, with delivery orders ranging from small transactions to substantial orders exceeding $45,000. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative plans multiple regional awards, positioning AmerisourceBergen as a strategic partner in supporting comprehensive military healthcare operations.
Quick answers
Who was awarded contract SPE2D826FA3HW?
SPE2D826FA3HW was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 5, 2026.
How much is contract SPE2D826FA3HW worth?
The government has obligated $13,817 on SPE2D826FA3HW.
Is contract SPE2D826FA3HW an order under another contract?
Yes. SPE2D826FA3HW is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA3HW competed?
The extent of competition for SPE2D826FA3HW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award